Summary:
This is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effectiveness of diabetes with the Eversense CGM System non-adjunctively compared to self-monitoring of blood glucose (SMBG) using a blood glucose (BG) meter in participants with either Type 1 or Type 2 diabetes.
- Subject has diabetes
- Subject is ≥18 years of age
- Subject has a smartphone that is internet enabled
- Subject is able to comply with study protocol tasks and understand written and verbal instructions in the investigator's opinion
- Subjects is willing and able to provide written signed and dated informed consent
Qualified Participants May Receive:
• No-cost study medication
• No-cost study-related care from a local doctor
• Compensation